Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-015746
Filing Date
2015-08-13
Accepted
2015-08-13 16:18:59
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sphs20150630_10q.htm 10-Q 1187288
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 13527
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14753
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7999
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 8049
  Complete submission text file 0001437749-15-015746.txt   4446835

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS sphs-20150630.xml EX-101.INS 843799
7 EXHIBIT 101.SCH sphs-20150630.xsd EX-101.SCH 46556
8 EXHIBIT 101.CAL sphs-20150630_cal.xml EX-101.CAL 35034
9 EXHIBIT 101.DEF sphs-20150630_def.xml EX-101.DEF 258133
10 EXHIBIT 101.LAB sphs-20150630_lab.xml EX-101.LAB 221078
11 EXHIBIT 101.PRE sphs-20150630_pre.xml EX-101.PRE 279229
Mailing Address 1258 PROSPECT STREET LA JOLLA CA 92037
Business Address 1258 PROSPECT STREET LA JOLLA CA 92037 858-777-1760
SOPHIRIS BIO INC. (Filer) CIK: 0001563855 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36054 | Film No.: 151050938
SIC: 2834 Pharmaceutical Preparations